New drug could be ‘gamechanger’ for chronic cough sufferers

Lung doctor says Gefapixant could be first new treatment for condition to be approved in UK for more than 50 yearsA new drug to treat chronic coughs could be a “gamechanger” treatment for the thousands of Britons who cough uncontrollably, many times a day.Prof Surinder Birring, a leading lung doctor, has led aglobal trial that found Gefapixant reduces a person ’s coughing by up to 60% and brings some relief to 70% of those who take it.Continue reading...

Source: Guardian Unlimited Science - October 5, 2022 Category: Science Authors: Denis Campbell Health policy editor Tags: Health policy Pharmaceuticals industry Medical research Science NHS Doctors Source Type: news